drugset / Trial / NCT00989911

Endothelin Blockade in Patients With Single Ventricle Physiology

NCT00989911

NaSingle-groupOpen-labelSupportive care

Summary

Recent studies have shown beneficial effects of sildenafil in patients with single ventricle congenital heart disease. The purpose of this study is to determine whether Bosentan, a drug with similar effects, will have similar benefit in this patient population.

Timeline

Start
2010-05
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosentan Other / unclassified 125 mg Oral